Future therapy in systematic lupus erythematosus

Mostrar todas las versiones(2)

Systemic Lupus erythematosus (SLE) is the model of systemic autoimmune disease characterized by multiple organ involvement and fluctuating disease activity. The prognosis of SLE improved significantly in the last decades and not only the possibility of greater therapeutic options but other factors s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Danielsen, Costanza, Alba, Paula, Babini, Alejandra M.
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2011
Materias:
lupus eritematoso sistémico
systematic lupus erythematosus
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/21537
Aporte de:
Revistas de la UNC de Universidad Nacional de Córdoba
id I10-R10article-21537
record_format ojs
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-10
container_title_str Revistas de la UNC
language Español
format Artículo revista
topic lupus eritematoso sistémico
systematic lupus erythematosus
spellingShingle lupus eritematoso sistémico
systematic lupus erythematosus
Danielsen, Costanza
Alba, Paula
Babini, Alejandra M.
Future therapy in systematic lupus erythematosus
topic_facet lupus eritematoso sistémico
systematic lupus erythematosus
author Danielsen, Costanza
Alba, Paula
Babini, Alejandra M.
author_facet Danielsen, Costanza
Alba, Paula
Babini, Alejandra M.
author_sort Danielsen, Costanza
title Future therapy in systematic lupus erythematosus
title_short Future therapy in systematic lupus erythematosus
title_full Future therapy in systematic lupus erythematosus
title_fullStr Future therapy in systematic lupus erythematosus
title_full_unstemmed Future therapy in systematic lupus erythematosus
title_sort future therapy in systematic lupus erythematosus
description Systemic Lupus erythematosus (SLE) is the model of systemic autoimmune disease characterized by multiple organ involvement and fluctuating disease activity. The prognosis of SLE improved significantly in the last decades and not only the possibility of greater therapeutic options but other factors such as the development of strategies related to the prevention and treatment of cardiovascular risk factors, infection control and immunization contributed to this advance.
publisher Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
publishDate 2011
url https://revistas.unc.edu.ar/index.php/med/article/view/21537
work_keys_str_mv AT danielsencostanza futuretherapyinsystematiclupuserythematosus
AT albapaula futuretherapyinsystematiclupuserythematosus
AT babinialejandram futuretherapyinsystematiclupuserythematosus
AT danielsencostanza terapiasfuturasenellupuseritematososistemico
AT albapaula terapiasfuturasenellupuseritematososistemico
AT babinialejandram terapiasfuturasenellupuseritematososistemico
bdutipo_str Revistas
_version_ 1764819782144622593

Ejemplares similares